TERESA WILSON: Open Payments
NPI 1710269220 · DOUGLAS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,203 in 48 payments from 13 companies in 2025. Trend: 2023 $2,085 · 2024 $2,049 · 2025 $1,203
Food & beverage: $1,203
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $304 |
| ABBVIE INC. | 10 | $231 |
| Novo Nordisk Inc | 4 | $157 |
| GlaxoSmithKline, LLC. | 5 | $106 |
| AstraZeneca Pharmaceuticals LP | 6 | $94 |
| Corcept Therapeutics | 4 | $80 |
| PFIZER INC. | 3 | $58 |
| Otsuka America Pharmaceutical, Inc. | 2 | $51 |
| Axsome Therapeutics, Inc. | 1 | $33 |
| Amgen Inc. | 2 | $31 |
Products named: CAPLYTA, VRAYLAR, Wegovy, TRELEGY ELLIPTA, BREZTRI, Korlym, REXULTI, NURTEC ODT.
Industry payments across GA — which companies pay providers there.
